Picture of Cerevel Therapeutics Holdings logo

CERE — Cerevel Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Cerevel Therapeutics Reports Third Quarter Financial Results

Nov 8 (Reuters) - Cerevel Therapeutics Holdings Inc
 CERE.O :
    * CEREVEL THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS UPDATES
    * QTRLY LOSS PER SHARE $0,66
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $1,030
MILLION AS OF SEPT 30
    * Q3 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5zyzwM 
Further company coverage:  CERE.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cerevel Therapeutics Holdings

See all news